Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest
Eli Lilly +5%, Named 'Top Pick' Following Q2 Beat Morgan Stanley Says
10 Health Care Stocks With Whale Alerts In Today's Session
Eli Lilly Tapping Bond Market for Morphic Deal -- Market Talk
Deutsche Bank: Eli Lilly (NYSE:LLY) Is a "High-Growth Unicorn"
Jim Cramer Considers Eli Lilly and Company (LLY) a 'Best of Breed' Stock
Eli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Express News | Market-Moving News for August 12th
Express News | Eli Lilly Files for Five Part, Notes Offering; Size Not Disclosed - SEC Filing
Express News | Eli Lilly Shares Are Trading Higher After Deutsche Bank Upgraded the Stock From Hold to Buy and Raised Its Price Target From $725 to $1,025
Big Tech, Health-Care and High-Yield Stocks Are Dip-Buying Targets
Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
Eli Lilly Analyst Ratings
Stock Market Movers: KeyCorp, Monday.com, Starbucks, Barrick Gold, and More
Express News | Eli Lilly and Company : Deutsche Bank Raises to Buy From Hold
Express News | Eli Lilly and Company : Deutsche Bank Raises Target Price to $1025 From $725
Bank of America raises Eli Lilly and Co's target price to $1125.
Bank of America: Raised the target price of Eli Lilly and Co from $1000 to $1125, maintaining a "buy" rating.
Barclays Remains a Buy on Eli Lilly & Co (LLY)
What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales